Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?
Annovis Bio(ANVS) Zacks Investment Research·2024-04-08 22:56
Shares of Annovis Bio, Inc. (ANVS) have gained 23.8% over the past four weeks to close the last trading session at 35.40 indicates a potential upside of 218.9%. The average comprises five short-term price targets ranging from a low of 72, with a standard deviation of $22.13. While the lowest estimate indi ...